US backs India’s proposal for patent waiver on vax, but EU still reluctant

Sandeep Dikshit

Tribune News Service

New Delhi, May 6

The US has relented to the six-month-old joint proposal of India and South Africa at the WTO asking for a temporary waiver of intellectual property (IP) rights on Covid vaccines and drugs.

If the European Union, the other major party blocking the waiver at the WTO, also agrees to a temporary waiver, many countries could quickly produce vaccines and life-saving medicines. They need not wait for the formalities and incur costs on patents and other IP-related rights to Covid-19 drugs, vaccines and other treatments.

However, this will not happen soon. Negotiations will take time because of the complexity of the issues involved and also because the decision at the WTO has to be unanimously adopted.

Issue compulsory licences for jabs, drugs: Cong

Congress leader Jairam Ramesh has asked the Centre to urgently invoke compulsory licensing provisions to make Covid jabs easily available.

Welcoming the US government’s announcement, India hoped the waiver would be approved quickly at the WTO. The MEA said the waiver was an important step for enabling rapid scaling up of manufacture and timely availability of affordable Covid vaccines and essential medical products. The US and the EU were outliers to the proposal, which has the support of 120 countries.

Washington’s changed stance was announced by US Trade Representative (USTR) Katherine Tai in a statement.

“The (US) administration’s aim is to get as many safe and effective vaccines to as many people as fast as possible. As our vaccine supply for the American people is secured, the administration will continue to ramp up its efforts—working with the private sector and all possible partners—to expand vaccine manufacturing and distribution. It will also work to increase the raw materials needed to produce those vaccines,” she said while “announcing the Biden-Harris administration’s support for waiving intellectual property protections for Covid vaccines”.

India and South Africa, later joined by other countries, including Pakistan, have been arguing before the WTO that IP rights could hinder the supply of vaccines and drugs at affordable prices. At a time when production needs to be scaled up, there should be “a waiver from the implementation, application and enforcement of patents, copyright and trademarks” in Covid-related areas.

Tai said the US will actively participate in text-based negotiations at the WTO “to make that happen”. The WTO will have to decide whether the waiver under Articles IX.3 and IX.4 should be granted to an individual country or collectively. The WTO has provided waivers under both modes in the past.

Sydney faces curbs after India-linked Mystery case

Australian officials reinstated social distancing measures across Sydney as they scrambled to find missing transmission links in a Covid case linked to an Indian variant.

SL bans India travellers

Sri Lanka on Thursday banned arrivals from India due to the record rise in Covid-19 cases in the neighbouring country.